Hypertension in athletes is underrecognized medical condition. It calls for screening for hypertension and unique principles that are applied for its management in this special group
SELF CARE IN HYPERTENSION by Dr. Alechenu.pptxIbrahimHamis2
This document provides an outline and overview of a presentation on self care practices for hypertension. It discusses the definition and epidemiology of hypertension, highlighting its prevalence globally and in some regions of Nigeria. The pathophysiology of essential hypertension is explained, noting the involvement of the kidney and brain. Common risk factors are identified. Self care practices recommended for patients with mild to moderate hypertension without other conditions include lifestyle modifications like weight control, physical activity, reducing sodium intake, following a DASH diet, cessation of smoking and alcohol, and relaxation techniques. Education of patients is also emphasized.
Ramadan fasting is ritual for all muslims worldwide , where there is abstinace from eating , drinking and smoking from dawn to dusk , daily for one month, frequently , hypertensives asking about their fasting and medications during Ramadan, in the lecture , some focus on the effect of Ramadan on blood pressure , heart rate and other cardiovascular risk factors and lastly general instruction for hypertensives during Ramadan .
This document discusses exercise prescription for individuals with hypertension. It begins by defining hypertension and describing the different classifications based on blood pressure levels. It then discusses lifestyle factors that can contribute to hypertension, as well as medications used to treat it. The document recommends that exercise testing may be useful for evaluating blood pressure response to exercise and guiding exercise prescription. For most individuals with controlled blood pressure, light-to-moderate intensity exercise like walking is sufficient without need for testing. The benefits of regular aerobic exercise for lowering blood pressure and reducing cardiac risks are outlined. Factors like medication side effects and target organ disease must be considered when developing an individual's exercise prescription. Moderate intensity aerobic exercise is generally recommended over vigorous exercise.
DrRic Taking the Hype out of Hypertension (slide share edition)DrRic Saguil
This document discusses hypertension guidelines and management. It begins with an anatomical and physiological overview before discussing guideline development organizations like JNC. Key points of the JNC7 guidelines are summarized, including classification thresholds and treatment recommendations. Lifestyle modifications like weight loss, following the DASH diet, reducing sodium, increasing physical activity, and moderate alcohol intake are reviewed as important non-pharmacological approaches to lowering blood pressure. The document concludes by advocating an individualized and multi-disciplinary approach to hypertension management.
The document discusses hypertension (HT), including its definition, epidemiology, diagnosis, risk factors, complications, investigation, management, and treatment. Some key points include:
- HT is defined as blood pressure over 140/90 mmHg. The prevalence of HT in the US is around 30% and in KSA around 26%.
- Risk factors include age, family history, obesity, smoking, diabetes, and lack of exercise. Complications affect the heart, blood vessels, brain, kidneys and eyes.
- Diagnosis involves taking accurate blood pressure readings on multiple occasions. Investigation includes routine tests like CBC and additional tests if needed.
- Treatment involves lifestyle changes like diet, exercise and weight
Moins Lecture Collection(Update Management of Hypertension 3).pdfMoinul Islam
This document provides guidance on the management of hypertension from the 2020 ISH Global Hypertension Practice Guidelines. It discusses definitions of hypertension, classification based on blood pressure levels, goals of therapy, and non-pharmacological and pharmacological treatment approaches. For treatment, it recommends initial lifestyle modifications and monotherapy before considering sequential monotherapy or combination drug therapy if blood pressure remains uncontrolled. It also provides guidance for specific circumstances like resistant hypertension, secondary hypertension, hypertension in pregnancy, and hypertensive emergencies.
This document provides guidelines for the treatment of hypertension. It discusses the definition and classification of hypertension according to the JNC 7 report. Evaluation of patients involves measuring blood pressure accurately, assessing risk factors, checking for target organ damage, and identifying secondary causes. Treatment goals depend on patient population, with the general goal being under 140/90 mmHg. Initial drug therapy involves thiazide diuretics, ACE inhibitors, ARBs, or CCBs. Lifestyle modifications including salt restriction, moderation of alcohol, regular exercise, weight control, and smoking cessation are also recommended.
This document provides clinical practice guidelines for the management of hypertension. It defines hypertension and classifies it into various types including isolated systolic, isolated office, and masked hypertension. It recommends evaluating patients to identify secondary causes, target organ damage, and risk factors. Treatment involves non-pharmacological lifestyle changes as well as drug therapy. Special populations like those with diabetes, renal disease, or the elderly may require different treatment goals or strategies. The guidelines cover initial assessment, treatment options including various drug classes, management of resistant/refractory cases, and special groups.
SELF CARE IN HYPERTENSION by Dr. Alechenu.pptxIbrahimHamis2
This document provides an outline and overview of a presentation on self care practices for hypertension. It discusses the definition and epidemiology of hypertension, highlighting its prevalence globally and in some regions of Nigeria. The pathophysiology of essential hypertension is explained, noting the involvement of the kidney and brain. Common risk factors are identified. Self care practices recommended for patients with mild to moderate hypertension without other conditions include lifestyle modifications like weight control, physical activity, reducing sodium intake, following a DASH diet, cessation of smoking and alcohol, and relaxation techniques. Education of patients is also emphasized.
Ramadan fasting is ritual for all muslims worldwide , where there is abstinace from eating , drinking and smoking from dawn to dusk , daily for one month, frequently , hypertensives asking about their fasting and medications during Ramadan, in the lecture , some focus on the effect of Ramadan on blood pressure , heart rate and other cardiovascular risk factors and lastly general instruction for hypertensives during Ramadan .
This document discusses exercise prescription for individuals with hypertension. It begins by defining hypertension and describing the different classifications based on blood pressure levels. It then discusses lifestyle factors that can contribute to hypertension, as well as medications used to treat it. The document recommends that exercise testing may be useful for evaluating blood pressure response to exercise and guiding exercise prescription. For most individuals with controlled blood pressure, light-to-moderate intensity exercise like walking is sufficient without need for testing. The benefits of regular aerobic exercise for lowering blood pressure and reducing cardiac risks are outlined. Factors like medication side effects and target organ disease must be considered when developing an individual's exercise prescription. Moderate intensity aerobic exercise is generally recommended over vigorous exercise.
DrRic Taking the Hype out of Hypertension (slide share edition)DrRic Saguil
This document discusses hypertension guidelines and management. It begins with an anatomical and physiological overview before discussing guideline development organizations like JNC. Key points of the JNC7 guidelines are summarized, including classification thresholds and treatment recommendations. Lifestyle modifications like weight loss, following the DASH diet, reducing sodium, increasing physical activity, and moderate alcohol intake are reviewed as important non-pharmacological approaches to lowering blood pressure. The document concludes by advocating an individualized and multi-disciplinary approach to hypertension management.
The document discusses hypertension (HT), including its definition, epidemiology, diagnosis, risk factors, complications, investigation, management, and treatment. Some key points include:
- HT is defined as blood pressure over 140/90 mmHg. The prevalence of HT in the US is around 30% and in KSA around 26%.
- Risk factors include age, family history, obesity, smoking, diabetes, and lack of exercise. Complications affect the heart, blood vessels, brain, kidneys and eyes.
- Diagnosis involves taking accurate blood pressure readings on multiple occasions. Investigation includes routine tests like CBC and additional tests if needed.
- Treatment involves lifestyle changes like diet, exercise and weight
Moins Lecture Collection(Update Management of Hypertension 3).pdfMoinul Islam
This document provides guidance on the management of hypertension from the 2020 ISH Global Hypertension Practice Guidelines. It discusses definitions of hypertension, classification based on blood pressure levels, goals of therapy, and non-pharmacological and pharmacological treatment approaches. For treatment, it recommends initial lifestyle modifications and monotherapy before considering sequential monotherapy or combination drug therapy if blood pressure remains uncontrolled. It also provides guidance for specific circumstances like resistant hypertension, secondary hypertension, hypertension in pregnancy, and hypertensive emergencies.
This document provides guidelines for the treatment of hypertension. It discusses the definition and classification of hypertension according to the JNC 7 report. Evaluation of patients involves measuring blood pressure accurately, assessing risk factors, checking for target organ damage, and identifying secondary causes. Treatment goals depend on patient population, with the general goal being under 140/90 mmHg. Initial drug therapy involves thiazide diuretics, ACE inhibitors, ARBs, or CCBs. Lifestyle modifications including salt restriction, moderation of alcohol, regular exercise, weight control, and smoking cessation are also recommended.
This document provides clinical practice guidelines for the management of hypertension. It defines hypertension and classifies it into various types including isolated systolic, isolated office, and masked hypertension. It recommends evaluating patients to identify secondary causes, target organ damage, and risk factors. Treatment involves non-pharmacological lifestyle changes as well as drug therapy. Special populations like those with diabetes, renal disease, or the elderly may require different treatment goals or strategies. The guidelines cover initial assessment, treatment options including various drug classes, management of resistant/refractory cases, and special groups.
This clinical case describes a 48-year-old man who presents for a routine checkup. On his initial visit, his blood pressure is elevated at 145/95 mmHg. One week later when he returns with a home blood pressure monitoring log, his blood pressure is higher at 160/100 mmHg. The case provides questions to test knowledge of appropriate treatment guidelines for this patient.
DrRic The Moorings Lecture on Hypertension (slide share edition)DrRic Saguil
This document discusses hypertension guidelines and treatment approaches. It provides an overview of hypertension guidelines from JNC committees since 1976, which establish blood pressure categories and treatment recommendations. It also discusses lifestyle changes that can help control blood pressure, such as weight loss, following the DASH diet, reducing sodium intake, physical activity, and moderating alcohol. Alternative approaches to medication are emphasized, including plant-based diets, stress reduction, and exercise tailored to individual needs and abilities.
this presentation will discuss hypertension management briefly and will concentrate more on morning hypertension as a separate entity and how to diagnose and treat such patients
This session will help pharmacists enhance their expertise in managing patients with hypertension through updates on the latest hypertension guidelines, discussion on the role that pharmacists can and should play in the detection and ongoing management of hypertension and hands-on experience with blood pressure measurement devices.
Hypertension, or high blood pressure, is caused by increased cardiac output and peripheral vascular resistance. It is classified as essential (primary) hypertension which is idiopathic or secondary which has an identifiable cause. Risk factors include family history, race, stress, obesity, sodium intake, alcohol, and tobacco use. Complications affect the heart, brain, kidneys and eyes. Diagnosis involves medical history, physical exam, and tests like ECG and bloodwork. Treatment focuses on lifestyle modifications and may include diuretics, beta blockers, ACE inhibitors, and other medications. Nursing care educates on compliance, diet, exercise and monitoring.
This document discusses the management of hypertension. Some key points include:
- Above 115/75 mmHg, cardiovascular disease risk doubles with each 20/10 mmHg increase in blood pressure.
- Prehypertension is defined as systolic BP of 120-139 mmHg or diastolic BP of 80-89 mmHg. Lifestyle modifications are recommended.
- Most patients require two or more drugs to achieve blood pressure goal. Initial drug therapy for most includes a thiazide-type diuretic.
- Lifestyle modifications like weight loss, adopting the DASH diet, reducing sodium intake, and increasing physical activity can significantly lower blood pressure.
This document discusses the management of a patient with congestive heart failure and hypertension. The patient presents with increased shortness of breath and leg swelling. Their medical history includes heart failure, hypertension for 30 years, and coronary artery disease.
The objectives of treatment are to decrease fluid retention, decrease the heart's workload, and increase myocardial contractility. Pharmacological interventions include loop diuretics to decrease fluid retention, ACE inhibitors to decrease workload, and beta adrenoceptor agonists to increase contractility. Non-pharmacological interventions such as diet, exercise, and smoking cessation are also recommended. The document discusses drug classes for hypertension and their mechanisms of action, efficacy, safety, and interactions. Management of the patient
Intervention in hypertension final.pptxAmeetRathod3
This document summarizes research on lifestyle interventions for hypertension. It finds that regular exercise, weight loss, adopting a healthy diet low in sodium and high in potassium, and maintaining good sleep habits can all help to lower blood pressure. While lifestyle changes can reduce blood pressure on their own, more significant effects are seen when multiple lifestyle factors are addressed together. The benefits of exercise and weight loss on blood pressure can be sustained long-term with continued maintenance of a healthy lifestyle.
Introduction, Integration of CM risk factors, Targeting obesity, Management of hypertension, Management of dyslipidemia, Antiplatelet therapy, Management of microalbuminuria, CB1 blockade
The document summarizes guidelines from the International Society of Hypertension (ISH), World Health Organization (WHO), American College of Cardiology/American Heart Association (ACC/AHA), and European Society of Cardiology/European Society of Hypertension (ESC/ESH) on the diagnosis and treatment of hypertension. It compares the guidelines on prevalence of hypertension, treatment thresholds and targets, drug choice and sequencing, and targets for specific patient groups. While the guidelines have some differences, they also have many similarities, including treatment targets of under 140/90 mmHg for most patients and under 130/80 mmHg for high-risk groups.
This document provides an overview of hypertension including:
1. Definitions of hypertension and classifications of blood pressure levels.
2. Techniques for measuring blood pressure such as in-office or ambulatory monitoring.
3. Epidemiology and risk factors for hypertension including increased prevalence with age.
4. Approaches to evaluating and managing patients with hypertension including lifestyle modifications, pharmacologic treatments, and treatment goals.
CHOs Final Yr. Congestive cardiac failure-2023.pptxIbrahimKargbo13
This document provides information on congestive cardiac failure (CCF), including:
1. The objectives are to describe heart anatomy, factors affecting cardiac output, treatment approaches, and drugs used to treat heart failure and hypertension.
2. Key factors that affect cardiac output are preload, afterload, and contractility. Drugs are used to regulate these factors.
3. CCF occurs when the heart cannot provide sufficient output to meet the body's needs. Main treatments are diuretics, ACE inhibitors, beta-blockers, vasodilators, and cardiac glycosides.
The document summarizes the key changes between the 2014 hypertension guidelines (JNC 8) and previous guidelines (JNC 7). The 2014 guidelines lower treatment thresholds based on rigorous evidence from randomized controlled trials. They recommend initiating treatment at SBP/DBP of 140/90 mmHg for those under 60, and 150/90 mmHg for those 60 and over. For those with diabetes or chronic kidney disease, the goal is SBP/DBP under 140/90 mmHg. Thiazide-type diuretics, ACE inhibitors, ARBs, calcium channel blockers are first-line treatments depending on population. The guidelines note limitations around scope and costs/adherence.
Management of hypertension and treatment optionsdrsanjayjain
Hypertension, or high blood pressure, affects nearly a billion people globally and is a major risk factor for cardiovascular diseases. Lifestyle modifications like following a healthy diet low in salt and high in fruits and vegetables, engaging in regular exercise, managing stress, avoiding tobacco and limiting alcohol can help control blood pressure. If lifestyle changes are not enough, medication like diuretics, ACE inhibitors, calcium channel blockers, and ARBs may be prescribed. Guidelines recommend initially treating hypertension with a diuretic, calcium channel blocker, ACE inhibitor or ARB, with thiazide diuretics being most effective. The goal is to reduce blood pressure below 140/90 mmHg to lower health risks.
Patient Counselling for Obese and Hypertensive Patient varshawadnere
This document provides information about counseling an obese and hypertensive patient. It discusses what patient counseling is, defines obesity and how it affects health, explains how obesity and hypertension are diagnosed and treated, and outlines the role of pharmacists in counseling patients about hypertension. The key objectives of patient counseling are to assess the patient's understanding of therapy, improve adherence, and motivate self-management.
This document discusses the diagnosis and treatment of resistant hypertension. It begins with definitions of uncontrolled and resistant hypertension, and discusses their epidemiology. It then outlines the diagnostic algorithm for evaluating resistant hypertension, including identifying pseudo-resistance and screening for secondary causes. Finally, it discusses new therapeutic options for resistant hypertension, including the use of mineralocorticoid receptor antagonists like spironolactone as additional treatment.
This document provides information on the definition, classification, causes, evaluation, and treatment of hypertension. It defines hypertension as a systolic blood pressure of 130 mm Hg or more or a diastolic blood pressure of 80 mm Hg or more, with a treatment goal of less than 130/80 mm Hg. Hypertension is a major risk factor for cardiovascular disease and is often caused by a combination of genetic and lifestyle/environmental factors. The document outlines guidelines for accurate blood pressure measurement, evaluation of target organ damage, and nonpharmacologic and pharmacologic treatment approaches.
1) Hypertension is poorly managed in the US, with only about 30% of patients achieving blood pressure control. Therapeutic inertia, where medication is not intensified despite uncontrolled blood pressure, contributes significantly to this problem.
2) Target organ damage from hypertension can include brain, heart, kidney, and eye damage, increasing risks of stroke, heart disease, and death.
3) Initial hypertension treatment typically involves a thiazide diuretic followed by an ACE inhibitor or ARB and calcium channel blocker. Lifestyle changes and frequent follow up are also important parts of management. Resistant hypertension may require up to 7 medications and evaluation for secondary causes.
The Art and Science of Management of Hypertension SYEDRAZA56411
Blood pressure measurement is a simple routine in daily medical practice. However, less emphasis is laid on if the blood pressure has been recorded using correct technique. The errors in blood pressure readings may be misleading in clinical decision making as well use or misuse of resources including patient harm or quality of care. This presentation probes one of similar issues . At the same time this would provide a practical guide to clinicians to optimally manage their hypertensive patients.
Underuse and Misuse of Newer Anti diabetic Medications in Patients at Risk an...SYEDRAZA56411
Are the newer anti-diabetic medications being prescribed after assessment of cardiovascular risk ?
Current practice in light of evidence and guidelines . What do the trial data tell us ?
This clinical case describes a 48-year-old man who presents for a routine checkup. On his initial visit, his blood pressure is elevated at 145/95 mmHg. One week later when he returns with a home blood pressure monitoring log, his blood pressure is higher at 160/100 mmHg. The case provides questions to test knowledge of appropriate treatment guidelines for this patient.
DrRic The Moorings Lecture on Hypertension (slide share edition)DrRic Saguil
This document discusses hypertension guidelines and treatment approaches. It provides an overview of hypertension guidelines from JNC committees since 1976, which establish blood pressure categories and treatment recommendations. It also discusses lifestyle changes that can help control blood pressure, such as weight loss, following the DASH diet, reducing sodium intake, physical activity, and moderating alcohol. Alternative approaches to medication are emphasized, including plant-based diets, stress reduction, and exercise tailored to individual needs and abilities.
this presentation will discuss hypertension management briefly and will concentrate more on morning hypertension as a separate entity and how to diagnose and treat such patients
This session will help pharmacists enhance their expertise in managing patients with hypertension through updates on the latest hypertension guidelines, discussion on the role that pharmacists can and should play in the detection and ongoing management of hypertension and hands-on experience with blood pressure measurement devices.
Hypertension, or high blood pressure, is caused by increased cardiac output and peripheral vascular resistance. It is classified as essential (primary) hypertension which is idiopathic or secondary which has an identifiable cause. Risk factors include family history, race, stress, obesity, sodium intake, alcohol, and tobacco use. Complications affect the heart, brain, kidneys and eyes. Diagnosis involves medical history, physical exam, and tests like ECG and bloodwork. Treatment focuses on lifestyle modifications and may include diuretics, beta blockers, ACE inhibitors, and other medications. Nursing care educates on compliance, diet, exercise and monitoring.
This document discusses the management of hypertension. Some key points include:
- Above 115/75 mmHg, cardiovascular disease risk doubles with each 20/10 mmHg increase in blood pressure.
- Prehypertension is defined as systolic BP of 120-139 mmHg or diastolic BP of 80-89 mmHg. Lifestyle modifications are recommended.
- Most patients require two or more drugs to achieve blood pressure goal. Initial drug therapy for most includes a thiazide-type diuretic.
- Lifestyle modifications like weight loss, adopting the DASH diet, reducing sodium intake, and increasing physical activity can significantly lower blood pressure.
This document discusses the management of a patient with congestive heart failure and hypertension. The patient presents with increased shortness of breath and leg swelling. Their medical history includes heart failure, hypertension for 30 years, and coronary artery disease.
The objectives of treatment are to decrease fluid retention, decrease the heart's workload, and increase myocardial contractility. Pharmacological interventions include loop diuretics to decrease fluid retention, ACE inhibitors to decrease workload, and beta adrenoceptor agonists to increase contractility. Non-pharmacological interventions such as diet, exercise, and smoking cessation are also recommended. The document discusses drug classes for hypertension and their mechanisms of action, efficacy, safety, and interactions. Management of the patient
Intervention in hypertension final.pptxAmeetRathod3
This document summarizes research on lifestyle interventions for hypertension. It finds that regular exercise, weight loss, adopting a healthy diet low in sodium and high in potassium, and maintaining good sleep habits can all help to lower blood pressure. While lifestyle changes can reduce blood pressure on their own, more significant effects are seen when multiple lifestyle factors are addressed together. The benefits of exercise and weight loss on blood pressure can be sustained long-term with continued maintenance of a healthy lifestyle.
Introduction, Integration of CM risk factors, Targeting obesity, Management of hypertension, Management of dyslipidemia, Antiplatelet therapy, Management of microalbuminuria, CB1 blockade
The document summarizes guidelines from the International Society of Hypertension (ISH), World Health Organization (WHO), American College of Cardiology/American Heart Association (ACC/AHA), and European Society of Cardiology/European Society of Hypertension (ESC/ESH) on the diagnosis and treatment of hypertension. It compares the guidelines on prevalence of hypertension, treatment thresholds and targets, drug choice and sequencing, and targets for specific patient groups. While the guidelines have some differences, they also have many similarities, including treatment targets of under 140/90 mmHg for most patients and under 130/80 mmHg for high-risk groups.
This document provides an overview of hypertension including:
1. Definitions of hypertension and classifications of blood pressure levels.
2. Techniques for measuring blood pressure such as in-office or ambulatory monitoring.
3. Epidemiology and risk factors for hypertension including increased prevalence with age.
4. Approaches to evaluating and managing patients with hypertension including lifestyle modifications, pharmacologic treatments, and treatment goals.
CHOs Final Yr. Congestive cardiac failure-2023.pptxIbrahimKargbo13
This document provides information on congestive cardiac failure (CCF), including:
1. The objectives are to describe heart anatomy, factors affecting cardiac output, treatment approaches, and drugs used to treat heart failure and hypertension.
2. Key factors that affect cardiac output are preload, afterload, and contractility. Drugs are used to regulate these factors.
3. CCF occurs when the heart cannot provide sufficient output to meet the body's needs. Main treatments are diuretics, ACE inhibitors, beta-blockers, vasodilators, and cardiac glycosides.
The document summarizes the key changes between the 2014 hypertension guidelines (JNC 8) and previous guidelines (JNC 7). The 2014 guidelines lower treatment thresholds based on rigorous evidence from randomized controlled trials. They recommend initiating treatment at SBP/DBP of 140/90 mmHg for those under 60, and 150/90 mmHg for those 60 and over. For those with diabetes or chronic kidney disease, the goal is SBP/DBP under 140/90 mmHg. Thiazide-type diuretics, ACE inhibitors, ARBs, calcium channel blockers are first-line treatments depending on population. The guidelines note limitations around scope and costs/adherence.
Management of hypertension and treatment optionsdrsanjayjain
Hypertension, or high blood pressure, affects nearly a billion people globally and is a major risk factor for cardiovascular diseases. Lifestyle modifications like following a healthy diet low in salt and high in fruits and vegetables, engaging in regular exercise, managing stress, avoiding tobacco and limiting alcohol can help control blood pressure. If lifestyle changes are not enough, medication like diuretics, ACE inhibitors, calcium channel blockers, and ARBs may be prescribed. Guidelines recommend initially treating hypertension with a diuretic, calcium channel blocker, ACE inhibitor or ARB, with thiazide diuretics being most effective. The goal is to reduce blood pressure below 140/90 mmHg to lower health risks.
Patient Counselling for Obese and Hypertensive Patient varshawadnere
This document provides information about counseling an obese and hypertensive patient. It discusses what patient counseling is, defines obesity and how it affects health, explains how obesity and hypertension are diagnosed and treated, and outlines the role of pharmacists in counseling patients about hypertension. The key objectives of patient counseling are to assess the patient's understanding of therapy, improve adherence, and motivate self-management.
This document discusses the diagnosis and treatment of resistant hypertension. It begins with definitions of uncontrolled and resistant hypertension, and discusses their epidemiology. It then outlines the diagnostic algorithm for evaluating resistant hypertension, including identifying pseudo-resistance and screening for secondary causes. Finally, it discusses new therapeutic options for resistant hypertension, including the use of mineralocorticoid receptor antagonists like spironolactone as additional treatment.
This document provides information on the definition, classification, causes, evaluation, and treatment of hypertension. It defines hypertension as a systolic blood pressure of 130 mm Hg or more or a diastolic blood pressure of 80 mm Hg or more, with a treatment goal of less than 130/80 mm Hg. Hypertension is a major risk factor for cardiovascular disease and is often caused by a combination of genetic and lifestyle/environmental factors. The document outlines guidelines for accurate blood pressure measurement, evaluation of target organ damage, and nonpharmacologic and pharmacologic treatment approaches.
1) Hypertension is poorly managed in the US, with only about 30% of patients achieving blood pressure control. Therapeutic inertia, where medication is not intensified despite uncontrolled blood pressure, contributes significantly to this problem.
2) Target organ damage from hypertension can include brain, heart, kidney, and eye damage, increasing risks of stroke, heart disease, and death.
3) Initial hypertension treatment typically involves a thiazide diuretic followed by an ACE inhibitor or ARB and calcium channel blocker. Lifestyle changes and frequent follow up are also important parts of management. Resistant hypertension may require up to 7 medications and evaluation for secondary causes.
The Art and Science of Management of Hypertension SYEDRAZA56411
Blood pressure measurement is a simple routine in daily medical practice. However, less emphasis is laid on if the blood pressure has been recorded using correct technique. The errors in blood pressure readings may be misleading in clinical decision making as well use or misuse of resources including patient harm or quality of care. This presentation probes one of similar issues . At the same time this would provide a practical guide to clinicians to optimally manage their hypertensive patients.
Underuse and Misuse of Newer Anti diabetic Medications in Patients at Risk an...SYEDRAZA56411
Are the newer anti-diabetic medications being prescribed after assessment of cardiovascular risk ?
Current practice in light of evidence and guidelines . What do the trial data tell us ?
Heart Failure Management -in light of Evidence Based Medicine and Guidelines SYEDRAZA56411
1) The document discusses evidence from the PARADIGM-HF trial comparing the ARNI drug sacubitril/valsartan to the ACE inhibitor enalapril in the treatment of heart failure with reduced ejection fraction.
2) The PARADIGM-HF trial found sacubitril/valsartan reduced the risks of cardiovascular death, all-cause mortality, and first hospitalization for heart failure compared to enalapril.
3) Sacubitril/valsartan also improved patients' quality of life as measured by the Kansas City Cardiomyopathy Questionnaire, with effects sustained over 36 months, whereas quality of life declined in patients taking enalapril
This document summarizes an ECG interpretation course covering Brugada syndrome, WPW syndrome, electrolyte imbalances, and the effects of digoxin. The course objectives are to understand Brugada syndrome and its associated polymorphic VT, WPW pattern on ECG and WPW syndrome, how electrolyte imbalances like hypomagnesemia can alter the ECG, and how digoxin affects the ECG. It also includes example ECGs and cases to test the interpretation of arrhythmias and electrolyte abnormalities.
1. The document provides tips for maintaining a healthy heart, including following a well-balanced diet, exercising regularly, reducing cholesterol, stopping smoking, managing stress, and controlling other health conditions.
2. It emphasizes that the two strongest risk factors for cardiovascular disease are an unhealthy diet and lack of physical activity.
3. The document advises seeking health information from reliable sources, recognizing warning signs of heart issues, and getting regular cardiac screenings to take the first steps toward a healthy heart.
Dyslipidemia -Assessment and management based on evidence SYEDRAZA56411
This document provides a summary of a presentation on dyslipidemia assessment and management. It discusses several key points:
1. International guidelines recommend intensive statin therapy to manage cardiovascular disease risk in patients with dyslipidemia.
2. Randomized trials like JUPITER showed that rosuvastatin reduced major cardiovascular events in individuals with elevated CRP levels despite normal lipid levels, supporting early prevention.
3. Guidelines worldwide advise lowering LDL-C based on cardiovascular risk, with intensive statin therapy recommended for high-risk patients to achieve LDL-C reduction of 50% or more.
The document discusses the benefits of exercise for mental health. Regular physical activity can help reduce anxiety and depression and improve mood and cognitive functioning. Exercise causes chemical changes in the brain that may help protect against mental illness and improve symptoms.
- Patients with cardiovascular disease have a higher mortality rate from COVID-19 according to data from China.
- The pathophysiology of cardiac involvement in COVID-19 can include hypoxia, hyperinflammation leading to cardiac dysfunction, direct viral myocarditis, and increased risk of thrombosis.
- Treatment is mainly supportive, though renin-angiotensin-aldosterone system inhibitors should generally be continued in stable patients, and immunosuppression or modulation may help in some cases.
Weight loss is not always a art but there is lot of science behind it.
This presentation will elude you to some science behind weight loss that will be effective as well as safer method.
This document outlines the agenda for a webinar on the health implications of COVID-19 from a global perspective. The webinar will feature five speakers who will discuss various topics related to COVID-19, including clots in COVID patients, the impact on mental health, practical radiology, and what is known about COVID-19 and heart health. There will also be a question and answer session and closing remarks. The webinar aims to provide an experiential learning opportunity on managing COVID-19 patients from medical experts based in several countries.
The document discusses the impact of sleep apnea on the cardiovascular system. Sleep apnea causes temporary pauses in breathing during sleep that reduce oxygen levels in the body. This leads to health issues like hypertension, arrhythmia, coronary artery disease, stroke, and heart failure. The document outlines the pathophysiological mechanisms by which sleep apnea affects the cardiovascular system, including hypoxia, increased sympathetic activity, and changes in intrathoracic pressure. Treatment with CPAP can help improve oxygenation, reduce blood pressure and sympathetic activity, and decrease cardiovascular risks.
This document provides information about COVID-19. It defines coronaviruses and explains that COVID-19 is a new disease caused by a recently discovered coronavirus. The most common symptoms of COVID-19 are fever, dry cough, and tiredness, though some patients experience additional symptoms like aches, sore throat, or loss of taste/smell. COVID-19 spreads primarily through respiratory droplets from infected individuals when they cough, sneeze or speak, and people can become infected by touching contaminated surfaces. There are currently no medicines that can prevent or cure COVID-19, so the most effective protections are frequent hand washing, avoiding touching the face, covering coughs and sneezes, and social distancing.
The document discusses COVID-19 complications and rehabilitation. It outlines that COVID-19 can involve multiple organs and lead to long-term complications. Rehabilitation is a holistic approach requiring a multi-disciplinary team to address physical, psychological, and social needs. The document emphasizes the importance of nutrition, exercise, counseling, social support, and vaccination to help patients return to normal functioning after COVID-19.
This document discusses key performance indicators (KPIs) and metrics for measuring healthcare operations management. It begins by outlining the objectives and levels of study for the module. It then defines process and outcomes measures that can be used. The document distinguishes between KPIs and the underlying metrics. It provides examples of common clinical and non-clinical metrics in healthcare like average length of stay, patient satisfaction, and operating margin. It also discusses quality metrics used by CMS and principles for effective KPI selection. Overall, the document provides an overview of how performance in healthcare can be measured using metrics and KPIs to enhance organizational performance.
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxwalterHu5
In some case, your chronic prostatitis may be related to over-masturbation. Generally, natural medicine Diuretic and Anti-inflammatory Pill can help mee get a cure.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
6. Describe the flow of current around the heart during the cardiac cycle
7. Discuss the placement and polarity of the leads of electrocardiograph
8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained
9. Define mean electrical vector (axis) of the heart and give the normal range
10. Define the mean QRS vector
11. Describe the axes of leads (hexagonal reference system)
12. Comprehend the vectorial analysis of the normal ECG
13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation
14. Explain the concepts of current of injury, J point, and their significance
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/
7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...rightmanforbloodline
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kolb, Ian Q. Whishaw, Verified Chapters 1 - 16, Complete Newest Versio
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kolb, Ian Q. Whishaw, Verified Chapters 1 - 16, Complete Newest Version
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kolb, Ian Q. Whishaw, Verified Chapters 1 - 16, Complete Newest Version
Histololgy of Female Reproductive System.pptxAyeshaZaid1
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
Here is the updated list of Top Best Ayurvedic medicine for Gas and Indigestion and those are Gas-O-Go Syp for Dyspepsia | Lavizyme Syrup for Acidity | Yumzyme Hepatoprotective Capsules etc
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPsychoTech Services
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...Donc Test
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler Community Health Nursing A Canadian Perspective, 5th Edition TEST BANK by Stamler Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Study Guide Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Studocu Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Course Hero Community Health Nursing A Canadian Perspective, 5th Edition Answers Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Course hero Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Studocu Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Study Guide Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Ebook Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Questions Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Studocu Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Stuvia
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central19various
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
8. Objectives
• 1. Size of the problem
• 2. Evaluation
• 3. Recommendations for sports participation
• 4. Management of blood pressure in athletes
9. Hypertension is the most common cardiovascular condition
affecting athletes.
The fundamental parameters defining hypertension in both adults
and children do not differ in athletes.
Usually identified in sports pre-participation medical evaluation
Requires a little different management strategy
13. 1. Prevalence 3%
2. All hypertensive
athletes achieved
optimal blood pressure
control.
3. Family history of HPN
and high BMI were
main risk factors
4. Life style
modification was
mainstay of treatment
to control BP in
majority
14. Measurement of blood
pressure
During a pre-participation examination, a trained clinician
should measure a resting blood pressure (BP) while the
1.Athlete is seated and relaxed, ideally for a period of five
minutes prior to the measurement.
2. Some athletes have large, muscular arms and an
appropriately sized BP cuff should be used.
3. If a properly measured BP is elevated at the first
examination, sports participation is permitted but a second
visit should be scheduled within a few weeks
24. General guideline for exercise and training
for hypertensive athletes and sportsmen
1. Warm up and cool down
2. Avoid heavy weight lifting
3. Avoid lifting weights above head
4. Avoid physically demanding static / isometric exercises
5. Prolonged breath hold and Valsalva maneuver to be discouraged.
27. Nonpharmacologic interventions
1. Weight loss 10 lb (4.5 kg) weight loss can reduce systolic blood pressure (SBP) 5 to 20 mmHg
2. Sodium restriction (limit salt added to food; avoid processed foods with high sodium content) 2
to 4 g/day can reduce SBP 2 to 8 mmHg
3. DASH diet (diet high in vegetables, fruits, low-fat dairy products, whole grains, poultry, fish, and
nuts; low in sweets, sugar-sweetened beverages, and red meats) can result in SBP reduction 8 to 14
mmHg
4. Alcohol restriction (no more than two drinks per day for men or one per day for women)
can lead to SBP reduction 2 to 4 mmHg
5. Aerobic exercise activity (three to four sessions per week of at least moderate intensity, each
session lasting at least 40 minutes) can cause SBP reduction 4 to 9 mmHg
6. Stress Management
28. Medical
therapy
If nonpharmacologic modifications fail to
reduce BP adequately in an athlete with
persistent hypertension, medical therapy is
required
The ideal medication controls BP without
compromising exercise capacity.
There is no fundamental difference in the
approach to the medical therapy of
hypertension in athletes compared with the
general population.
29. Choice of anti-
hypertensive
drugs
1.Review of list of prohibited drugs/medications (World
Anti-Doping Association)
2.ACEI and ARB preferred first line as they do not
interfere with exercise performance. C/I= Reproductive
age female athletes.
3. Calcium channel blocker ( not rate limiting) as second
choice
4. Beta blocker to be avoided = a. HR <50/mt b. Heart
blocks c. considered doping agent in sports like shooting
and archery as may mask tremors.
5.Diuretics should be avoided / banned as they mask
performance enhancing drugs and interfere in sports due
to frequent urination.
30.
31. Persistent
hypertension
Athletes with hypertension that has persisted for
a longer period (6 to 12 months) or that has not
responded to lifestyle modifications and
pharmacotherapy should be assessed with an
echocardiogram.
The echocardiogram distinguishes between
pathologic changes associated with chronic
hypertension and normal adaptations in
athletes.
Athlete Heart = Eccentric or concentric LVH
with increased LV volume
Hypertension = Concentric LVH with reduced
LV volume
32. During
Competition
Generally, antihypertensive medications
should be continued during competition. If
an appropriate medication is chosen, there
is no need to withhold it.
Diuretics and beta- blocker should be
avoided
As a general rule, any new medication
should be given for at least one week prior
to any competitive event to help avoid any
unanticipated problems.
33. Medications and
Supplements that
can exacerbate
Hypertension or its
complications
• Human growth hormone, Androgen
hormones, Nonsteroidal anti-inflammatory
drugs
• Stimulants can increase BP : caffeine,
nicotine, ephedrine-containing over-the-
counter decongestants, ephedrine containing
herbal remedies, and amphetamines
• Creatine is the most widely used supplement
that may exacerbate the harmful effects of
hypertension, specifically renal function.
34. Prognosis
• The potential long-term complications from
hypertension in athletes are thought to be
similar to those in the general population, and
include myocardial infarction, stroke, renal
failure, and death
• Hypertension is not recognized as a cause of
exertional sudden cardiac arrest.
• LVH if present should be differentiated for
underlying etiology
35. Summary
Hypertension is one of the commonest
medical problems associated with athletes
Prevalence is very much dependent on cut
off threshold for diagnosis
Risk assessment is important to guide sports
participation and blood pressure management
Clear guideline exists on choice of medication
Editor's Notes
A bodybuilder and sprinter who has set multiple world records in his age group in races ranging from 60 meters to 400 meters, Eugster is basically the fittest 96-year-old on the planet
Classification of different sports disciplines. Sport disciplines are divided according to acute physiologic responses (i.e. heart rate and blood pressure) and long-term impact on cardiac output and remodelling.45,46 Skill sports: achievement depends on technical or bodily skill. Increase in heart rate is accompanied by modest increase in blood pressure and cardiac output. No cardiac remodelling. Power sports: achievement depends on explosive muscle power (i.e. high-static exercise). Substantial increase in heart rate and blood pressure during repeated bursts. Cardiac remodelling with increase in left ventricular wall thickness and modest increase in left ventricular cavity size and function occurs. Mixed sports: alternating phases of dynamic and/or static work and recovery (e.g. ball and team sports). Duration and exercise intensity vary largely according to type of sport and the role the athlete plays. Phasic increases in heart rate and blood pressure may reach near-maximum values, alternating with recovery phases. There is cardiac remodelling with increase in left ventricular cavity size and modest change in left ventricular wall thickness. Endurance sports: prolonged and intensive high dynamic, often associated with high-static exercise at near maximal cardiac output, through increase in heart rate, and blood pressure over several hours. Cardiac remodelling with significant increase in left ventricular cavity size and wall thickness is present. -/þ: no, þ: weak, þþ: moderate, and þþþ: strong effect. 3668 J. Niebauer et al. Downloaded from https://academic.oup.com/eurheartj
Edward (Eddie) Hall - World’s strongest man 2017 - Deadlift of 500kgs (1100 pounds ) - estimated blood pressure rise 300/180 mmhg at the end stated to bleed from nose and ears and passed out.